跳至主要内容
MedPath Trial Home
临床试验
产品
机构
资讯
AI 研究
价格
Search
EN
登录
我们重视您的隐私
我们使用 Cookie 分析网站流量并改善您的体验。请参阅我们的
隐私政策
。
拒绝
接受
SIR2
首页
药物
SIR2
SIR2
未知生产厂商
订阅
生成 AI 研报
Share to Twitter
Share to Facebook
Share to LinkedIn
Share to Reddit
摘要
临床试验
审批记录
专利
每项发明一条,涵盖美国、欧洲、PCT 与中国的同族专利。
Non-platinum metal complexes for excimer based single dopant white organic light emitting diodes
US 10793546 B2
申请人: UNIV ARIZONA STATE
优先权: 2014
US
WO
7 件公开
Electroactive materials
US 8308988 B2
申请人: MENG HONG
优先权: 2008
US
7 件公开
Sir2 products and activities
US 6987091 B2
申请人: EINSTEIN COLL MED
优先权: 2002
US
6 件公开
Monomer, Polymer, and Method of Making it
US 2012095184 A1
申请人: MCKIERNAN MARY
优先权: 2009
CN
US
WO
4 件公开
SIR2 regulation
US 8383653 B2
申请人: EINSTEIN COLL MED
优先权: 2004
US
4 件公开
Expansion of stem/progenitor cells by inhibition of enzymatic reactions catalyzed by the Sir2 family of enzymes
US 8187876 B2
申请人: PELED TONY
优先权: 2005
US
4 件公开
NOVEL COMPOSITIONS FOR PREVENTING AND TREATING NEURODEGENERATIVE AND BLOOD COAGULATION DISORDERS
EP 1850840 A2
申请人: SIRTRIS PHARMACEUTICALS INC
优先权: 2005
EP
US
WO
3 件公开
USE OF SIRTUIN-ACTIVATING COMPOUNDS FOR TREATING FLUSHING AND DRUG INDUCED WEIGHT GAIN
EP 1841415 A2
申请人: SIRTRIS PHARMACEUTICALS INC
优先权: 2005
EP
US
WO
3 件公开
METHODS AND RELATED COMPOSITIONS FOR TREATING OR PREVENTING OBESITY, INSULIN RESISTANCE DISORDERS, AND MITOCHONDRIAL-ASSOCIATED DISORDERS
EP 1898897 A2
申请人: SIRTRIS PHARMACEUTICALS INC
优先权: 2005
CN
EP
WO
3 件公开
CN 101257897 A
申请人: SIRTRIS PHARMACEUTICALS INC
优先权: 2005
CN
US 2007149466 A1
申请人: MILBURN MICHAEL
优先权: 2006
US
Polymerizable compositions based on epoxides
US 2002002212 A1
申请人: ESPE DENTAL AG
优先权: 2001
US
2 件公开
第 1 / 5 页
上一页
下一页
药物
反馈